Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in sprague-dawley rats from two major suppliers

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 1, 2012, Pages 173-182

  Griffin, Karen ^a   Polichnowski, Aaron ^a   Licea Vargas, Hector ^a   Picken, Maria ^b   Long, Jianrui ^c   Williamson, Geoffrey ^c   Bidani, Anil ^a  

^a Veterans Administration Hospital   (United States)

^b LOYOLA UNIVERSITY   (United States)

^c Illinois Institute of Technology   (United States)

Author keywords

Hypertension; Proteinuria; Radiotelemetry; Remnant kidney; Renal mass reduction

Indexed keywords

N(G) NITROARGININE METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; BODY WEIGHT; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DISEASE MODEL; DISEASE PREDISPOSITION; HISTOLOGY; HYPERTENSION; KIDNEY DISEASE; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION;

EID: 83455223833     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00070.2011     Document Type: Article

References (39)

1. Abu-Amarah I, Bidani AK, Hacioglu R, Williamson GA, Griffin KA. Differential effects of salt on renal hemodynamics and potential pressure transmission in stroke-prone and stroke-resistant spontaneously hypertensive rats. Am J Physiol Renal Physiol 289: F305-F313, 2005.
2. Bachmann S, Bosse HM, Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol Renal Fluid Electrolyte Physiol 268: F885-F898, 1995.
3. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 294: F1-F9, 2008.
4. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90: 278-281, 1992.
5. Baylis C, Qiu C. Importance of nitric oxide in the control of renal hemodynamics. Kidney Int 49: 1727-1731, 1996.
6. Bidani AK, Griffin KA, Williamson G, Wang X, Loutzenhiser R. Protective importance of the myogenic response in the renal circulation. Hypertension 54: 393-398, 2009.
7. Bidani AK, Hacioglu R, Abu-Amarah I, Williamson GA, Loutzenhiser R, Griffin KA. "Step" vs. "dynamic" autoregulation: implications for susceptibility to hypertensive injury. Am J Physiol Renal Physiol 285: F113-F120, 2003.
8. Boffa JJ, Lu Y, Placier S, Stefanski A, Dussaule JC, Chatziantoniou C. Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol 14: 1132-1144, 2003.
9. Buhimschi IA, Shi SQ, Saade GR, Garfield RE. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies. Am J Obstet Gynecol 184: 686-693, 2001.
10. Elger M, Sakai T, Kriz W. The vascular pole of the renal glomerulus of rat. Adv Anat Embryol Cell Biol 139: 1-98, 1998.
11. Erdely A, Freshour G, Baylis C. Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat. Am J Physiol Regul Integr Comp Physiol 290: R66-R72, 2006.
12. Erdely A, Wagner L, Muller V, Szabo A, Baylis C. Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase. J Am Soc Nephrol 14: 2526-2533, 2003.
13. Fujihara CK, De Nucci G, Zatz R. Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J Am Soc Nephrol 5: 1498-1507, 1995.
14. Gladwin MT, Raat NJ, Shiva S, Dezfulian C, Hogg N, Kim-Shapiro DB, Patel RP. Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation. Am J Physiol Heart Circ Physiol 291: H2026-H2035, 2006.
15. Griffin KA, Abu-Amarah I, Picken M, Bidani AK. Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent. Hypertension 41: 201-206, 2003.
16. Griffin KA, Bidani AK, Ouyang J, Ellis V, Churchill M, Churchill PC. Role of endothelium-derived nitric oxide in hemodynamic adaptations after graded renal mass reduction. Am J Physiol Regul Integr Comp Physiol 264: R1254-R1259, 1993.
17. Griffin KA, Hacioglu R, Abu-Amarah I, Loutzenhiser R, Williamson GA, Bidani AK. Effects of calcium channel blockers on "dynamic" and "steady-state step" renal autoregulation. Am J Physiol Renal Physiol 286: F1136-F1143, 2004.
18. Griffin KA, Picken M, Bidani AK. Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol 4: 2023-2031, 1994.
19. Griffin KA, Picken MM, Bidani AK. Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest 96: 793-800, 1995.
20. Gschwend S, Buikema H, Navis G, Henning RH, de Zeeuw D, van Dokkum RP. Endothelial dilatory function predicts individual susceptibility to renal damage in the 5/6 nephrectomized rat. J Am Soc Nephrol 13: 2909-2915, 2002.
21. Hill GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens 17: 266-270, 2008.
22. Just A, Arendshorst WJ. Nitric oxide blunts myogenic autoregulation in rat renal but not skeletal muscle circulation via tubuloglomerular feedback. J Physiol 569: 959-974, 2005.
23. Kang DH, Nakagawa T, Feng L, Johnson RJ. Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol 161: 239-248, 2002.
24. Kone BC, Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol Renal Physiol 272: F561-F578, 1997.
25. Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee. Arterioscler Thromb Vasc Biol 25: 478-479, 2005.
26. Mattson DL, Kunert MP, Roman RJ, Jacob HJ, Cowley AW Jr. Substitution of chromosome 1 ameliorates L-NAME hypertension and renal disease in the fawn-hooded hypertensive rat. Am J Physiol Renal Physiol 288: F1015-F1022, 2005.
27. Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell- Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 18: 539-550, 2007.
28. Nakayama T, Sato W, Kosugi T, Zhang L, Campbell-Thompson M, Yoshimura A, Croker BP, Johnson RJ, Nakagawa T. Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse. Am J Physiol Renal Physiol 296: F317-F327, 2009.
29. Olson JL. Renal Disease Caused by Hypertension. Philadelphia, PA: Lippincott-Raven, 2005.
30. Polichnowski AJ, Cowley AW Jr. Pressure-induced renal injury in angiotensin II versus norepinephrine-induced hypertensive rats. Hypertension 54: 1269-1277, 2009.
31. Pollock DM, Rekito A. Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers. Am J Physiol Regul Integr Comp Physiol 275: R1719-R1723, 1998.
32. Raij L. Nitric oxide, salt sensitivity, and cardiorenal injury in hypertension. Semin Nephrol 19: 296-303, 1999.
33. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20: 298-303, 1992.
34. Shi Y, Wang X, Chon KH, Cupples WA. Tubuloglomerular feedbackdependent modulation of renal myogenic autoregulation by nitric oxide. Am J Physiol Regul Integr Comp Physiol 290: R982-R991, 2006.
35. Van Dokkum RP, Jacob HJ, Provoost AP. Genetic differences define severity of renal damage after L-NAME-induced hypertension in rats. J Am Soc Nephrol 9: 363-371, 1998.
36. Wang X, Cupples WA. Interaction between nitric oxide and renal myogenic autoregulation in normotensive and hypertensive rats. Can J Physiol Pharmacol 79: 238-245, 2001.
37. Yoshioka T, Rennke HG, Salant DJ, Deen WM, Ichikawa I. Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: a study in early passive Heymann nephritis. Circ Res 61: 531-538, 1987.
38. Zatz R, Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension 32: 958-964, 1998.
39. Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 17: 2664-2669, 2006.